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Primary spindle cell sarcoma of the left atrium is an extremely rare tumour. Surgical
excision is the mainstay of treatment since it responds poorly to chemotherapy or radio-
therapy. In spite of all the treatment, the prognosis remains poor due to inadvertent delay
in diagnosis, few therapeutic options and propensity to metastasize. We present a 47-year-
old male who underwent a surgical excision of a left atrial mass in February 2010. It was
proved to be a high-grade spindle cell sarcoma on histopathology. He presented again in
October 2010 with recurrence of the tumour for which he was re-operated. However, the
tumour recurred again within one month, to which the patient succumbed.
Copyright ª 2012, Cardiological Society of India. All rights reserved.1. Introduction sarcomas have a poor prognosis in spite of surgicalThe most common type of benign primary cardiac tumours
is myxomas. The most common malignant type of primary
cardiac tumours is sarcomas.1,2 Both myxomas and
sarcomas often have a similar presentation. Therefore
many sarcomas are misdiagnosed as myxomas. However
both these types of cardiac tumours behave quite
distinctly. Myxomas can be completely resectable and
therefore have an excellent prognosis. On the other hand,diology, Jaslok Hospital,
. Desai).
2012, Cardiological Socieresection.1,2
There are very few case reports of primary spindle cell
sarcomas of the left atrium from India.3 We would like to
presentacaseofa leftatrial spindlecell sarcomawhopresented
with a recurrence within 6e7 months of his first surgery and
again 1 month after his second surgery. Based on initial work
up, he was diagnosed to have a left atrial myxoma but his
histopathology revealed spindle cell sarcoma. Thus accurate
diagnosis is extremely important in determining theprognosis.15 Dr. G. D. Deshmukh Marg, Mumbai 400026, India. Tel.: þ91
ty of India. All rights reserved.
Fig. 1 e Pre operative echocardiography showing a left
atrial mass.
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A 47-year-old male, presented on 26th February 2010 with
symptoms of heaviness in the chest on exertion, dyspnoea on
exertion NYHA grade II and giddiness for 1 week. Therewas no
variation of symptoms related to posture. There were no asso-
ciated symptoms of syncope or cough. There were no consti-
tutional symptoms like fever, weight loss or appetite loss.
On examination, the patient had a heart rate of 94 beats per
minute, regular; blood pressure was 122/70 mmHg, supine.
Cardiovascular system revealed a normal first and second
heart sound with a grade II/III, soft, low pitched, mid diastolic
murmur without any thrill. His respiratory, abdominal and
neurological examinations were unremarkable.
The patient’s haematological and serological investiga-
tions were within normal limits. An electrocardiogram
showed sinus tachycardia. 2D Echocardiography showed
a large solitary mass arising from the lateral wall of the left
atrium, close to the inter-atrial septum. It was broad based,
occupying nearly the entire left atrium and was mobile. It
prolapsed into the left ventricle during diastole. The left
ventricular ejection fraction was 60%. There was mild mitral
regurgitation. There was no pericardial effusion.
On 27th February 2010, the patient underwent surgery for
excision of the left atrial mass via a median sternotomy.
Intraoperatively, the tumour was found to be adhearant to the
postero-lateral wall of the left atrium, extending into the
pulmonary veins. Its consistencywas firm to hard. A near total
excision was done without excising any part of the atrial wall.
There was no extension into the myocardium, pericardium or
other adjacent structures. Features which raised doubt about
the benign nature of this mass were that it was arising from to
the postero-lateral wall of the left atrium unlike myxomas
which usually arise from the inter-atrial septum, its consis-
tency was firm to hard, it extended into the pulmonary veins
and it was adherent to the atrial wall.
The histopathology revealed a 5  3  3 cm firm polypoid
smooth mass, which on microscopy showed an apparent
sarcomatous tumour composed of spindle shaped cells in
flowing fascicles supported by a myxomatous matrix. This
was diagnosed as a high-grade spindle cell sarcoma of the left
atrium.
Post operatively the patient’s symptoms improved and he
was subsequently discharged.
Follow up Echocardiography in May 2010 showed no
residual mass and a left ventricular ejection fraction of 55%.
However, an echocardiography done in September 2010
showed a 2.4 1.2 cm sessile, broad basedmass occupying the
left atrium, arising from the lateral wall, not reaching up to the
mitral valve with trivial mitral regurgitation. There was no
pericardial effusion. The patient failed to take the recom-
mended treatment at that time.
On 16th October 2010, the patient was readmitted with
symptoms of sudden onset breathlessness NYHA grade II
since 3e4 days, which rapidly progressed to NYHA grade IV
within 4 days. There was no postural variation of the
symptoms.
On examination, the patient had a heart rate of 128 beats
per minute, regular; blood pressure was 110/78mmHg supine.Cardiovascular system revealed a normal first and second
heart sound with a short mid diastolic murmur and no other
sounds.
A 2D Echocardiography showed a 5  3 cm mass arising
from the lateral wall of the left atrium, close to the inter-atrial
septum impinging on the mitral valve and prolapsing into the
left ventricle during diastole. It was sessile, broad based and
occupying nearly the entire left atrium. There was no peri-
cardial effusion (Fig. 1). A CT Scan of the chest and abdomen
showed a 6.2  3.3  5.0 cm soft tissue space occupying lesion
occupying almost the entire left atrial chamber, bilateral
moderate pleural effusion (left > right sided) & peri-hilar
pulmonary congestion.
The patient was re-operated on 18th October 2010 and the
mass in the left atrium was excised via a right anterolateral
thoracotomy. The tumour was hard in consistency. It arose
from the postero-lateral wall of the left atrium andwas tightly
adherent to the atrial wall which precluded total excision of
the tumour. There was no involvement of the myocardium or
pericardium. Hence debulking of the mass was carried out to
relieve the obstructive symptoms. The histopathology report
revealed a 7  5  5 cm nodular mass (Fig. 2), which on
microscopy showed a fairly well circumscribed cellular
tumour consisting of bundles of spindle shaped cells sepa-
rated by myxoid stroma (Fig. 3). The nuclei of the cells were
pleomorphic and exhibited 15e20 mitosis per ten high power
fields. The tumour cells stained positively with Vimentin. CD
34, SMA and Desmin were negative. The diagnosis was
a poorly differentiated spindle cell sarcoma of the left atrium.
The patient improved symptomatically. The post operative
Echocardiography showed no residual mass in the left atrium
(Fig. 4). The patient had an uneventful recovery and was dis-
charged on the 23rd of October 2010.
Within one month of discharge, the patient developed
recurrent symptoms of breathlessness on exertion and was
readmitted on 18th November 2010. An Echocardiography
showed a 2.8  3.0 cm mass in the left atrium causing left
ventricular inflow obstruction (Fig. 5). The patient was started
on a palliative chemotherapy consisting of Dacarbazine and
Fig. 2 e Gross pathology of cardiac spindle cell sarcoma.
Fig. 4 e Post operative echocardiography (four chamber
view).
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vention and expired on 27th November 2010 due to Cardiac
failure and Nosocomial Pneumonia.3. Discussion
Primary cardiac neoplasms are rare with an incidence varying
between 0.001 and 0.28%.1 Metastatic disease of the heart is
20e40 times more common than primary cardiac neoplasms.
Among primary cardiac tumours, approximately 75% are
benign of which cardiac myxomas account for majority. The
remaining 25% of cardiac neoplasms are malignant; sarcomas
being the most common, accounting for half to three quarters
of the cases.2 Benign cardiac tumours are more common on
the left side of the heart whereas malignant ones are more
common on the right side of the heart.
Malignant primary cardiac tumours include angiosarco-
mas, rhabdomyosarcomas, leiomyosarcomas, fibrosarcomas,
malignant fibrous histocytomas, undifferentiated sarcomas
and malignant lymphomas. Primary cardiac angiosarcoma is
the most common primary cardiac sarcoma in adults and
rhabdomyosarcoma is the most common primary cardiac
sarcoma in children. Cardiac spindle cell sarcomas areFig. 3 e Histopathology of cardiac spindle cell sarcoma.classified as undifferentiated sarcomas. They lack a specific
histology, with negative immunohistochemistry for desmin,
factor VIII, and keratin. They typically involve the left atrium,
and may extend to the pericardium resulting in a hemoper-
icardium. This is in contrast to angiosarcomas, which have
a predilection for the right atrium.4,5
Cardiac sarcomas can have a varied presentation. They can
present with sudden onset, intermittent or positional symp-
toms of chest discomfort, dyspnoea, orthopnoea, cough or
syncope. They may present with heart failure, pericardial
effusion and tamponade, arrythmias, valvular abnormalities,
obstructive symptoms depending on the chamber of the heart
involved. Embolic episodes resulting in systemic emboli, brain
being the most common site or pulmonary emboli can be
a presenting feature.2 Non-specific constitutional symptoms
such as fever, fatigue and weight loss can occur in 10%
without cardiac symptoms.1 Frequently, sarcomas presentFig. 5 e Recurrence of left atrial mass (parasternal long axis
view).
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nodes, adrenal and brain. Rarer presentations include supe-
rior vena cava syndrome, myocardial infarction or cardiac
rupture. On examination, an audible tumour plop may be
heard due to protrusion of the tumour through the mitral
valve. There may be murmurs that may have positional vari-
ation or signs of left or right-sided cardiac failure. Due to their
rarity, they may bemisdiagnosed as mitral stenosis or cardiac
myxomas.
The diagnosis is usually established using non-invasive
modalities such as trans-thoracic or trans-esophageal echo-
cardiography. CT scan and cardiacMRI are useful in predicting
the malignant nature of the cardiac mass. Tumour location,
tissue composition and pericardial or pleural effusions are key
predictors of lesion type.6 Features suggestive of malignancy
are broad based lesions, lesions occupying the entire cardiac
chamber, infiltration of the myocardium, pericardium or
adjacent structures, hilar lymphadenopathy, necrosis and
metastases. Definitive diagnosis is made by tissue biopsy,
which may be obtained by transvenous or percutaneous
biopsy, endoscopy, mediastinoscopy or thoracotomy.
However, individual subtypes of cardiac sarcomas do not
affect the outcome. Prognosis depends on the grade of the
tumour, which is based on the mitotic activity, necrosis and
degree of cellular differentiation. High mitotic activity (>5
mitotic figures/10 high power fields), extensive tumour
necrosis and poor cellular differentiation have a worse
prognosis.2
Cardiac sarcomas have poor prognosis with a mean
survival of less than 1 year. In rare cases prolonged survival
has been documented.7 Surgical debulking is the mainstay of
the treatment. It serves as palliative treatment to relieve
symptoms. Bench surgery (explantation and auto-
transplantation of the heart) has been tried to achieve
complete resection of the tumour.8 The role of orthotropic
heart transplantation for malignant cardiac tumours is
controversial.9 Neo-adjuvant chemotherapy to reduce the
tumour mass and facilitate surgical excision can be tried.Adjuvant chemotherapy (with regimens combining several
agents, usually including doxorubicin) or radiation therapy
may play a role in some cases. In spite of treatment, the
prognosis remains poor with the most common cause of
death being recurrence of the tumour.Conflicts of interest
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